Toxic Impurities in Active Pharmaceutical Ingredients 2019 is a webinar that covers topics such as:
- Handling trace analysis
- General Information about the limits for toxic impurities
- Structure and properties of NDEA
- Structure and properties of NDMA
- How are nitrosamines formed?
- Structure and properties of NMBA
- Some thoughts on other potential toxic impurities
- How did it get in sartans?
Toxic Impurities in Active Pharmaceutical Ingredients 2019 is intended for:
- Research and Development Departments
- Quality Departments
- Validation Departments
- Regulatory Affairs Departments
- Everyone involved with New Product Selection
- Everyone involved with Analytical Method Development and Validation
